Increased production of interferon γ but not interleukin 4 in human T-lymphotropic virus type I carriers

International Journal of Hematology

Volumn 64, Issue 2, 1996, Pages 111-118

  Shimamoto, Yoshinori ^a   Funai, Noriko ^a   Watanabe, Masayuki ^a   Suga, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Cytokine; Monocyte; Retrovirus; T lymphocyte

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CARRIER;

EID: 0030219963     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(96)00472-0     Document Type: Article

References (51)

1. [1] Hollsberg P, Hafler DA. Pathogenesis of disease induced by human lymphotropic virus type I infection. N Engl J Med 1993;328:1173-1182.
2. [2] Takatsuki K, Yamaguchi K, Watanabe T et al. Adult T-cell leukemia and HTLV-I related diseases. In: Takatsuki K, Hinuma Y and Yoshida M. (eds). Advances in adult T-cell leukemia and HTLV-I research. Tokyo: Japan Scientific Societies, 1992;1-15.
3. [3] Okamoto T, Ohno Y, Tsugane S et al. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 1989;80:191-195.
4. [4] Yodoi J, Uchiyama T, Maeda M. T cell growth factor receptor in adult T cell leukemia. Blood 1983;63: 509-510.
5. [5] Uchiyama T, Hori T, Tsudo M et al. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J Clin Invest 1985;76:446-453.
6. [6] Depper JM, Leonard WJ, Kronke M, Waldmann TA, Greene WC. Augmented T cell growth factor receptor expression in HTLV-I-infected human leukemic T cells. J Immunol 1984;133:1691-1695.
7. [7] Gootenberg JE, Ruscetti FW, Mier JW, Gazdar A, Gallo RC. Human cutaneous T cell lymphoma and leukemic cell line produce and respond to T cell growth factor. J Exp Med 1981;154:1403-1418.
8. [8] Arima N, Daitoku Y, Yamamoto Y et al. Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells. J Immunol 1987;138:3069-3074.
9. [9] Uchiyama T, Kamino M, Kodaka T et al. Leukemic cells from some adult T-cell leukemia patients proliferate in response to interleukin-4. Blood 1988;72:1182-1186.
10. [10] Shirakawa F, Tanaka Y, Oda S, Eto S, Yamashita U. Autocrine stimulation of interleukin 1α in the growth of adult human T-cell leukemia cells. Cancer Res 1989;49:1143-1147.
11. [11] Mori Y, Yamashita U, Tanaka Y et al. Interleukin-4 induces proliferation of adult T-cell leukemia cells. Eur J Haematol 1993;50:133-140.
12. [12] Tamura K, Makino S, Araki Y, Imamura T, Seita M. Recombinant interferon beta and gammma in the treatment of adult T-cell leukemia. Cancer 1987;59: 1059-1062.
13. [13] Koyama Y, Tanaka Y, Oda S, Yamashita U, Eto S. Antiviral and antiproliferative activities of recombinant human interferon α2, β and γ on HTLV-I and ATL cells in vitro. J UOEH 1990;12:149-161.
14. [14] Aggarwall BB, Aiyer RA, Pennica D, Gray PW, Goeddel DV. Human tumor necrosis factor: structure and receptor interactions. In: Bock G and Marsh J. (eds). Tumor necrosis factor and related cytotoxins. Chichester: John Wiley & Sons Ltd, 1987;39-51.
15. [15] Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RI. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
16. [16] Mosmann TR. Cytokine patterns during the progression to AIDS. Science 1994;265:193-194.
17. [17] Mahanty S, Abrams JS, King CL, Limaye AP, Nutmann TB. Parallel regulation of IL-4 and 1L-5 in human helminth infection. J Immunol 1992;148:3567-3571.
18. [18] Taylor-Robinson A, Phillips RS, Severn A, Moncada S, Liew FY. The role of TH1 and TH2 cells in a rodent malaria infection. Science 1993;260:1931-1934.
19. [19] Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993;91:1390-1395.
20. [20] Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med 1994;179:347-351.
21. + cell numbers and clinical staging. J Clin Invest 1989;84:1892-1899.
22. [22] Clerici M, Hakim FT, Venzon DJ et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-765.
23. [23] Clerici M, Shearer GM. A TH1 - TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
24. [24] Taguchi H, Kobayashi M, Miyoshi I. Immunosuppression by HTLV-I infection. Lancet 1991;337:308.
25. [25] Nakada, Kohakura M, Komoda H, Hinuma Y. High incidence of HTLV-I antibody in carriers of Strongyloides stercoralis. Lancet 1984:1:633.
26. [26] Tokudome S, Tokunaga O, Shimamoto Y et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan, Cancer Res 1989;49:226-228.
27. 3 and the effects of interferon γ. J Leukocyte Biol 1993; 54:40-46.
28. [28] Matsuzaki M, Shimamoto Y, Watanabe M, Kukita A, Yoshida S, Tadano J. Intracellular multiplication of Legionella pneumophila in HL-60 cells functionally differentiated in response to 22-oxacalcitriol. J Leukocyte Biol 1995;57:574-580.
29. [29] Shimamoto Y, Kikuchi M, Funai N, Suga K, Matsuzaki M, Yamaguchi M. Spontaneous regression in adult T-cell leukemia/lymphoma. Cancer 1993;72:735-740.
30. [30] Shimamoto Y, Suga K, Shibata K, Matsuzaki M, Yano H, Yamaguchi M. Clinical importance of extraordinary integration patterns of human T-cell lymphotrophic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood 1994;84:853-858.
31. [31] Kobayashi S, Yoshida T, Hiroshige Y et al. Comparative studies of commercially available particle agglutination assay and enzyme-linked inununosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors. J Clin Microbiol 1988;26: 308-312.
32. [32] Yamaguchi K, Matsutes E, Kiyokawa T et al. Comparison of immunoperoxidase staining with indirect immunofluorescence, ELISA and Western blotting assays for detecting anti-HTLV-I antibodies in systemic lupus erythematosus. J Clin Pathol 1988;41:57-61.
33. 3. J Interferon Cytokine Res 1996;16:347-356.
34. [34] Morecki S, Topalian SL, Myers WW, Okrongly D, Okamura TB, Rosenberg SA. Separation and growth of human CD4 and CD8 tumor infiltrating lymphocytes and peripheral blood mononuclear cells by direct positive panning on covalently attached monoclonal antibody coated-flasks. J Biol Resp Modif 1990;9:463-474.
35. [35] Bronstein I, Voyta JC, Thorpe GHG, Kricka LJ, Armstrong G. Chemiluminescent assay of alkaline phosphatase applied in an ultrasensitive enzyme immunoassay of thyrotropin. Clin Chem 1989;35:1441-1446.
36. [36] Tendler CL, Greenberg SJ, Burton JD et al. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retrovirus pathogenesis. J Cell Biochem 1991;46: 302-311.
37. [37] Graziosi C, Pantaleo G, Gnatt KR et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994;265:248-252.
38. [38] Watanabe H, Nakamura T, Nagasato K et al. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy. Arch Neural 1995;52:276-280.
39. [39] Sen GC, Lengyel P. The interferon system: a bird's eye view of its biochemistry. J Biol Chem 1992;267: 5017-5020.
40. [40] Vercelli D, Jabara HH, Lauener RP, Geha RS. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 1990;144:570-573.
41. + human T-cells. J Immunol 1991;146:4209-4214.
42. [42] Coffman RL, Carty JA. T-cell activity that enhance polyclonal IgE production and its inhibition by interferon-γ. J Immunol 1986;136:949-954.
43. [43] Ohnishi K, Ichikawa A, Kagami Y et al. Interleukin 4 and γ-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma. Cancer Res 1990;50:8028-8033.
44. [44] Vowels BR, Cassin M, Vonderheid EC, Rook AH. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 1992;99:90-94.
45. [45] Tendler CL, Burton JD, Jaffe J et al. Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res 1994;54:4430-4435.
46. [46] LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infeciton. Lancet 1990;336: 1345-1347.
47. [47] Dinarello C. Interleukin-1 and interleukin-1 antagonist. Blood 1991;77:1627-1652.
48. [48] Wong GHW, Goeddel DV. Tumor necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 1986;323:819-822.
49. + tumor-infiltrating lymphocytes. J Exp Med 1991;173:647-658.
50. [50] Yamaguchi K, Kiyokawa T, Nakada K et al. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. Br J Haematol 1988;68:169-174.
51. [51] Yasuda K, Sei Y, Yokoyama MM, Tanaka K, Hara A. Healthy HTLV-I carriers in Japan: the haematological and immunological characteristics. Br J Haematol 1986;64:195-203.